Abstract
Introduction
Physical exercise is important in cardiovascular rehabilitation (CR). The physical assessment of patients before starting treatment is thus essential. 1 ---5 In this respect, cardiopulmonary exercise testing (CPET) measures several variables related to cardiorespiratory function, including peak oxygen consumption (VO 2 max ), 6, 7 and is considered the gold standard for determining VO 2 max . 8---13 However, because it is complex and requires maximum effort, CPET is not commonly used in clinical practice. 8,9,11,13---24 For example, 12% of patients with coronary artery disease are unable to perform the test with maximal effort. 25 Therefore, field tests have been developed to predict VO 2 max and to identify functional limitations, enabling VO 2 max to be used more regularly in clinical practice.
Several field tests are used in CR. The 6-minute walk test (6MWT; the longest distance walked in 6 minutes), 26, 27 provides firm evidence of response to clinical changes. 10 It correlates with VO 2 max in CPET in patients with heart failure 28---30 and is sensitive to changes in perception of disease symptoms. 31 Moreover, the Shuttle Walk Test (longest distance walked in a 10-meter corridor with gradual increase in intensity) has been used in post-operative coronary artery bypass grafting (CABG) patients, 32 heart failure patients 33 and in Chagas disease. 34 Step tests are also used in patients with respiratory diseases 35 suspected coronary obstruction 36 and in elderly patients with heart failure. 37---39 They require little space and are easy to transport and simple to perform. 40 However, the literature on the effects of CR programs on field test performance is inconsistent. Conductingfurther trials is important and other research models would enable an integrated analysis of published results. In this context, systematically reviewing the literature makes it possible to search for and include references using defined and robust strategies, and a meta-analysis allows a mathematical model to be used to identify potential variables affecting outcome. We did not find any meta-analyses focusing on field tests and CR. As such, the aim of this study was to systematically review the literature on field tests used in CR programs and to perform a meta-analysis to identify (1) the effect of CR on field test performance and (2) training variables that may influence CR effect.
Methods

Search strategy and selection of trials
Tw o researchers (CFT and RRP) independently conducted a literature review in the MEDLINE/PubMed and Web of Science databases. Articles were selected from their date of publication up to May 2016. Doubts concerning article selection were resolved jointly by the researchers based on the proposed inclusion criteria. Medical descriptors standardized by Medical Subject Heading were used, along with terms and expressions in the title or abstract. The following inclusion criteria were taken into account: (1) articles in English, including randomized and non-randomized clinical trials; (2) human subjects (men and/or women over 18 years of age); (3) diagnosis of heart disease; (4) participants in outpatient CR programs; (5) exercise capacity evaluated by means of exercise tests independently of CPET; (6) presence of training-prescription variables; (7) control group. Figure 1 Flowchart of the selection process of articles included in the systematic review.
Trials included in the systematic review
We initially identified 1767 articles in both databases, of which 259 were excluded because they were duplicates and 1318 were excluded after analysis of the title and abstract. After reading the remaining trials in full, 15 were used for this review (Figure 1 ).
Data extraction and quality analysis
The data on trial quality, journal impact factor, year of publication, gender, age, weight, height, body mass index (BMI), ejection fraction (EF), VO 2 max , training volume, training intensity, type of training, training location, type of field test used and field test results were independently extracted by two evaluators (CFT and RRP) to a specific spreadsheet. General concordance was 0.92 using Cohen's kappa coefficient. Discordances were resolved by face-toface discussion. The comparison of field-test values between the experimental and control groups of the trials included was the primary outcome. Trial quality was assessed using the Physiotherapy Evidence Database (PEDro) scale, which has been reported to be valid 56 and reproducible. 57 Scoring was performed twice and any doubts were resolved jointly. Articles were not excluded based on the quality result.
Statistical analysis
Calculation of the effect size Effect size (g) was used to quantify changes in field test performance following the CR period (aerobic training or aerobic+resistance training). Effect size was defined as the standardized mean difference, corrected for bias (Hedges's g), in field test performance for the experimental and control groups. We initially calculated the paired difference (experimental mean-control mean) and the standard deviation (SD) of the paired difference (experimental SD 2 +control SD 2 -2×inter-trial correlation×experimental SD×control SD) 1/2 to determine the standardized mean difference (SMD). We then determined the SMD (paired difference×(2-2×inter-trial correlation)) 1/2 ÷(paired difference of SD) and standard error (SE) of the SMD ((1/n+SMD 2 ÷(2×n)) 1/2 ×(2-2×inter-trial correlation)) 1/2 . Finally, the correction factor obtained with the formula 1-{3÷[4× (n total-2)-1]} was multiplied by the SMD to obtain Hedges's g. When the study reported only the SE, the SD was calculated by multiplying the SE by the square root of the sample number, n. No study provided inter-trial group data (correlation between data from the experimental and control groups), so this value was assumed to be 0.5 for all studies. Positive g values indicated increased performance compared to the control group values.
The Q-statistic was calculated to determine whether the degrees of similarity among the effect sizes were significant. It was converted into a standardized measurement of heterogeneity (I 2 statistic) and values of 25%, 50% and 75% indicated low, moderate or high heterogeneity, respectively. Risk of bias was analyzed by funnel plot vs. SMD. Publication bias was analyzed using Egger's non-parametric regression (two-tailed) and the method proposed by Duval and Tweedie.
Subset and moderator variable analyses
Meta-analysis and meta-regression were performed using the Comprehensive Meta-Analysis program (version 2.2, Biostat Inc., Englewood, NJ, USA) using a random-effects model and Hedges's g correction factor. For significant heterogeneity, moderator variable analysis was used to explain the g-value variability in the outcomes. Potential moderator variables included age, gender, BMI, weight, height, baseline EF, baseline VO 2 , training time, weekly frequency, duration of aerobic exercise, quality of the trials (PEDro scale), journal impact factor and year of publication of the study.
Subset analysis included the variables type of exercise (aerobic, aerobic+resistance), type of aerobic exercise (walking, bicycle, walking and/or bicycle), type of training (continuous, progressive), training place (home or clinic), type of disease and procedure (angina, myocardial infarction, heart failure, angioplasty and coronary artery bypass grafting). Any differences between subsets were analyzed by Q test based on the analysis of variance (ANOVA).
Results
Description of included trials
The general details of the trials included are described in Table 1 . We identified 15 trials published between 1996 and 2016. The total sample consisted of 932 patients (701 men and 191 women). In one trial 48 with 40 participants, the number of men and women was not specified. The mean age was between 54.4 and 75.3 years. Fourteen trials used the 6MWT to assess exercise capacity and one study used the Shuttle Walk Test. 48 For the statistical analysis of subsets and moderator variables, we therefore considered only trials that used the 6MWT. Only seven studies 42, 43, 45, 49, 52, 54, 55 used CPET in combination with field testing.
Te n trials were conducted in patients with heart failure, 41---47,52,54,55 two in patients following myocardial infarction, 51, 53 one in patients with angina, 48 one in postangioplasty and CABG patients 49 and one in pre-operative CABG patients. 50 CR was unsupervised in only one 47 of the 10 trials conducted in patients with heart failure. Mean training duration lasted from six 44 stair machine, 43 and arm ergometer, 41 while one study 44 did not specify the type of exercise. Seven trials 41, 42, 46, 49, 50, 52, 55 used muscle-strengthening exercises, including three studies with equipment, 41, 49, 52 three with gym bands 46, 50, 55 and one with circuit. 42 The duration of aerobic exercise ranged from 10 47 to 90 minutes. 44 Tw o trials 51, 53 were conducted in patients following myocardial infarction, although CR was unsupervised and the aerobic exercise was walking (four weeks, four times a week). In addition, one trial 48 was conducted in angina patients in a supervised program (circuit, once a week for eight weeks), another was conducted in post-angioplasty and CABG patients (three times a week for 12 weeks; aerobic exercises on bicycle and resistance exercises with body weight and equipment), 49 while a third 50 was conducted in pre-operative CABG patients (twice a week for 16 weeks; aerobic exercises on bicycle and walking and resistance exercises with body weight and gym bands). In general, duration of aerobic exercise ranged from 10 54,55 to 80 minutes. 48 Figure 2 shows the effect size of the 15 trials. The data were analyzed in meters, taking into account the pre-and posttest means and SDs of the control and experimental groups, as well as the number of subjects in each session. The data were found to be heterogeneous (Q=42.0; degrees of freedom=14; I 2 =66.7%; p<0.001). Hedges's g using the random model was 0.617 (0.373-0.86; p<0.001), which meant a 20% increase in test performance after cardiovascular rehabilitation. Table 2 shows the continuous variables analyzed by meta-regression. Only three variables showed significant results: duration of aerobic exercise (p=0.01), baseline VO 2 max (p<0.01) and final VO 2 max (p=0.01). In this context, for each 1-minute increase in duration of aerobic exercise, g increased by 0.02 in field test performance. This did not occur for baseline and final VO 2 max . Instead, for each 1 ml/kg/min reduction in baseline VO 2 max , g increased by 0.23, and for each 1 ml/kg/min reduction in final VO 2 max , g increased by 0.08. Continuous variables, such as the intensity of aerobic and resistance training, and the number of sets and reps, were not subjected to meta-regression, since the data were presented in broad ranges, hindering meta-regression analysis and stratification for analysis by categorical variables. Table 3 shows categorical variable subsets analyzed by the Q test based on ANOVA. In this group of variables, the duration of aerobic exercise was stratified into three categories (30-35 minutes, 45 minutes; >60 minutes). Duration of over 60 minutes had a significantly larger g than the 30-35 minute duration. In addition, a difference was noted in relation to the type of training; effect size was greater for progressive training than for continuous training.
Field test and meta-analysis
No publication bias was identified using Egger's regression (p=0.06) and the method proposed by Duval and Tweedie (K=15; Q=31.38).
Discussion
The aim of this study was to determine the effect size and the variables that influence the results of field tests used in CR programs. The results showed a predominance of 6MWT, which was used in 14 of the 15 trials. The primary outcome was a 20% increase in final vs. baseline field test performance. In addition, performance was associated with progressive aerobic exercise training, longer duration of exercise, and baseline and final VO 2 max values.
Aerobic exercise has been established as beneficial to patients with heart failure, through central (increased cardiac output, ventricular remodeling and modulation of the sympathetic nervous system) and peripheral mechanisms (increased peripheral muscle perfusion and increased extraction and use of oxygen). 58 In patients with preserved EF, there was an increase in VO 2 max due to improved muscle and microvascular function. 59 In patients with coronary artery disease, aerobic exercise slows progression and reduces the size of atherosclerotic plaques, improves endothelial function and increases left ventricular EF after myocardial infarction. 60 Therefore, our results in relation to the recommendation for aerobic exercise reinforce the data in the literature. Moreover, our study found that better field test performance was obtained based on progressive aerobic exercise, rather than maintaining the same load effort throughout the training period. In this context, as long as physical and clinical conditions allow the patient to handle relatively greater effort after a training period, a gradual increase in intensity may help improve performance. However, data from the references in this study were not conclusive about the best effort intensity or the progression model, because in most of the trials these data were given in broad ranges that did not enable suitable statistical analyses.
Regarding the duration of aerobic exercise, our results showed that the greatest effect occurred in direct relation to the duration of exercise. However, of the 15 trials included, nine used exercise duration of between 30 and 45 minutes; only two studies used one exceeding 60 minutes. Although our results showed that for every 1-minute increase in exercise duration, there was a 0.02 increase in g, this does not necessarily mean that extremely long exercise durations would be positive for the patient. Thus, it is hasty to assume that heart disease patients should perform aerobic exercise for more than 60 minutes. Other trials should therefore be conducted with durations greater than 60 minutes to better analyze results.
Regarding VO 2 max , the meta-regression showed a significant relationship between both baseline and final values and field test performance. This suggests that patients with a lower physical fitness level at the start of CR respond better than patients with a higher level. Similarly, patients with a lower fitness level at the end of the CR had a better effect size. These patients tended to have a better response in the field test after CR. In line with our findings, a meta-analysis study 61 demonstrated that baseline VO 2 max was a predictor of exercise capacity after CR. In addition, the trial found that exercise intensity was another predictive variable of exercise capacity at the end of the rehabilitation program.
However, some other variables did not correlate with increased performance, such as gender, height, weight and BMI. Considering that 6MWT was predominantly used and can be affected by anthropometric differences, we could assume that being taller or heavier affected performance. However, one possible reason that this assumption was not confirmed may be due to the clinical characteristics of the samples. Because we included only trials with patients and not healthy individuals, differences in height, weight and gender did not have the statistical power to influence results. However, the trials did not report separate outcomes for gender or BMI cutoff points when they were present. Therefore, even though our study did not detect a relationship between these variables and test performance, confirmation is still needed. In addition to anthropometric variables, CR duration and weekly treatment frequency did not affect final performance. This may be explained by the difficulty of analysis due to the heterogeneity of protocols regarding the type of supervision, type of aerobic exercise, and duration and intensity of training.
In addition to the physiological variables or training variables, data related to journal impact factor, trial quality and year of publication were also analyzed. These analyses were included to detect bias in trials with different qualities, published in periodicals with different impact factors or published in different years. However, no relationships between these variables and the final outcome were identified.
Conclusions
The primary outcome of this systematic review with metaanalysis was increased field test performance following CR, and that a longer duration of aerobic exercise equates to better performance. These results may contribute to the prescription of CR exercise sessions.
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